Latest Articles

Publication Date
All News Scientific
Petition hits 100k after mum misdiagnosed with endometriosis died of cancer - Lincolnshire Live

Petition hits 100k after mum misdiagnosed with endometriosis died of cancer Lincolnshire Live

Published: Dec. 12, 2024, 1:13 p.m.
Read Full Article
Crossed 35? You Need To Watch Your Weight To Reduce Breast Cancer Risk - Medical Daily

Crossed 35? You Need To Watch Your Weight To Reduce Breast Cancer Risk Medical Daily

Published: Dec. 12, 2024, 9:31 a.m.
Read Full Article
Young Mom Diagnosed With Stage 4 Breast Cancer Weeks After Clear Mammogram Reveals Overlooked Symptoms - Medical Daily

Young Mom Diagnosed With Stage 4 Breast Cancer Weeks After Clear Mammogram Reveals Overlooked Symptoms Medical Daily

Published: Dec. 12, 2024, 6:34 a.m.
Read Full Article
Endometrial Cancer Market Diagnosing and Treating a Growing - openPR

Endometrial Cancer Market Diagnosing and Treating a Growing openPR

Published: Dec. 11, 2024, 10:11 a.m.
Read Full Article
Early Recurrence After Surgery in FIGO 2023 Stage I-III Endometrial Cancer: Characteristics and risk factors - Frontiers

Early Recurrence After Surgery in FIGO 2023 Stage I-III Endometrial Cancer: Characteristics and risk factors Frontiers

Published: Dec. 10, 2024, 4:36 p.m.
Read Full Article
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - BioSpace

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer BioSpace

Published: Dec. 10, 2024, 12:23 p.m.
Read Full Article
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - Yahoo Finance

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer Yahoo Finance

Published: Dec. 10, 2024, 11 a.m.
Read Full Article
IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer - PR Newswire

IDEAYA Announces First-Patient-In for Phase 1 Clinical Trial Evaluating IDE161 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Endometrial Cancer PR Newswire

Published: Dec. 10, 2024, 11 a.m.
Read Full Article
IDEAYA Launches Breakthrough Phase 1 Trial: Novel PARG Inhibitor + KEYTRUDA for Endometrial Cancer - StockTitan

IDEAYA Launches Breakthrough Phase 1 Trial: Novel PARG Inhibitor + KEYTRUDA for Endometrial Cancer StockTitan

Published: Dec. 10, 2024, 11 a.m.
Read Full Article
From Night Sweats To Changes In Bowel Habits: Colorectal Cancer Survivor Reflects On Red Flags He Overlooked - Medical Daily

From Night Sweats To Changes In Bowel Habits: Colorectal Cancer Survivor Reflects On Red Flags He Overlooked Medical Daily

Published: Dec. 10, 2024, 7:22 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!